«
Stem cell study opens door to undiscovered world of biology.»
Not exact matches
ONC201 may inhibit cancer
stem cell self - renewals by altering their gene expression, according to a
study published August 2, 2017 in the
open - access journal PLOS ONE by Varun Vijay Prabhu from Oncoceutics, Inc., USA and colleagues.
A team led by Joseph Ecker of the Salk Institute for Biological
Studies in California recently made significant progress in discerning how
stem cells keep their options
open.
The
stem cells that proliferate the most in response to damage caused by cigarette smoke repair their DNA using a process prone to errors, setting the stage for lung cancer, according to a
study publishing January 26, 2017 in the
open - access journal PLOS Biology by Marie - Liesse Asselin - Labat and her team of the Walter and Eliza hall Institute of Medical Research, Australia.
This advance in breast cancer research reflects the mission of
Stem Cell Reports to provide an open - access forum that communicates basic discoveries in stem cell research as well as translational and clinical stud
Stem Cell Reports to provide an open - access forum that communicates basic discoveries in stem cell research as well as translational and clinical stud
Cell Reports to provide an
open - access forum that communicates basic discoveries in
stem cell research as well as translational and clinical stud
stem cell research as well as translational and clinical stud
cell research as well as translational and clinical
studies.
The results, published in the current issue of Human Molecular Genetics,
open the door for pursuing gene editing in nonhuman primates as models for new therapies, including pharmacological, gene - and
stem cell - based therapies, said Keith Latham, MSU animal science professor and lead author of the
study.
A Phase 3
Open - Label Randomized
Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3 - ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First - line Treatment With or Without Hematopoietic
Stem Cell Transplantation (HSCT) Consolidation
Previously,
studies of
stem cell transplants for heart disease have only been performed in patients already scheduled for
open heart surgery.
A Phase III Randomized
Open - Label Multi-Center
Study of Ruxolitinib vs. Best Available Therapy in Patients with Corticosteroid - Refractory Chronic Graft vs Host Disease after Allogenic
Stem Cell Transplantation (REACH 3)
Now, in a
study published in
Stem Cells, the laboratory of Seung Hyun Kim (Hanyang University, Seoul, Korea) report on an
open ‐ label, single ‐ arm, investigator ‐ initiated trial to identify biological markers of MSCs to predict response to in patients with ALS [3].
Doctors at Okyanos utilize a specifically developed Okyanos protocol for
opening up the blood brain barrier to help deliver
stem cells directly to the brain; a technique that has been proven effective in independent
studies This enables doctors to target your
stem cells inside the brain to re-establish blood flow and repair damaged nerve
cells (neurons) as well as target the restoration of myelin, halting the future progression of symptoms.
Issues Per Year: 12 issues per year Aims and Scope:
Stem Cell Reports is an open access forum communicating basic discoveries in stem cell research, in addition to translational and clinical stud
Stem Cell Reports is an open access forum communicating basic discoveries in stem cell research, in addition to translational and clinical stud
Cell Reports is an
open access forum communicating basic discoveries in
stem cell research, in addition to translational and clinical stud
stem cell research, in addition to translational and clinical stud
cell research, in addition to translational and clinical
studies.
It also
opens up potential avenues in embryology that would have been inconceivable otherwise — for example, using
stem cells to accurately
study the embryology of whales and other species with much longer (or shorter) gestation rates than humans.
The results have been organized in an interactive,
open - access database with a number of novel features and search tools to promote
studies into the biological properties of embryonic
stem cells.
Today, this
study presents tangible progress for patients with a devastating genetic brain disease and
opens the door for application to other neurological diseases that are treatable with hematopoietic
stem -
cell transplantation.